| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/23/2009 | US7550432 Recombinant fusion proteins to growth hormone and serum albumin |
| 06/23/2009 | US7550429 treating mammal to a weight reduction or reduction in obesity; biodrug as antilipolytic agents |
| 06/23/2009 | US7550427 Poly-pegylated protease inhibitors |
| 06/23/2009 | US7550296 Identifying functional insertion sites within the genome of a replication competent target virus; result in an increase in the selectivity and efficiency of gene therapy |
| 06/23/2009 | US7550295 using modified vaccinia topoisomerase enzyme containing an affinity tag to facilitate purification of protein-DNA complexes away from unbound DNA; ligating duplex DNAs; cloning DNA by introducing into a cell ligated duplex DNA |
| 06/23/2009 | US7550293 Chimeric nicotinic receptor subunits |
| 06/23/2009 | US7550281 Method for production of alpha-amylase in recombinant Bacillus |
| 06/23/2009 | US7550280 Lipases and uses thereof |
| 06/23/2009 | US7550275 Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide |
| 06/23/2009 | US7550274 Glucose dehydrogenase |
| 06/23/2009 | US7550266 Methods and systems for dynamic gene expression profiling |
| 06/23/2009 | US7550265 Process for removal of homopolymeric sequence portion from analyte(s) and library of analytes |
| 06/23/2009 | US7550263 Fetoproteins; pharmacokinetics; biocompatability; rheumatoid arthritis; multiple sclerosis; cancer |
| 06/23/2009 | US7550257 Hyperpolarizing with potential-sensitive fluorescent dye and isoosmolar sodium-ion-free buffer, incubating, determining membrane potential, adding sodium, recording change in potential; voltage sensitive oxonol dyes; sodium channel modulators; high throughput screening; fluorescent imaging plate reader |
| 06/23/2009 | US7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/23/2009 | US7550145 Adjuvant compositions |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | CA2406443C Method for quantification of akt protein expression |
| 06/23/2009 | CA2387267C Methods of optimizing antibody variable region binding affinity |
| 06/23/2009 | CA2373466C Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (eaoh) |
| 06/23/2009 | CA2337494C Herpes virus vectors for dendritic cells |
| 06/23/2009 | CA2286395C Production method of heterologous protein |
| 06/23/2009 | CA2266860C Gas-driven particle delivery device |
| 06/23/2009 | CA2251696C Genetic suppression and replacement |
| 06/23/2009 | CA2226101C Expression of ocean fish antifreeze peptide in a food grade organism and its application in food products |
| 06/23/2009 | CA2173822C Cytoplasmic expression of antibodies, antibody fragments and antibody fragment fusion molecules in e. coli |
| 06/23/2009 | CA2163456C New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 06/23/2009 | CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 06/23/2009 | CA2104767C A chemiluminescent method for the quantitation of human dna |
| 06/23/2009 | CA1341597C Mutant human tissue-type plasminogen activator with a modified carbohydrate structure at amino acid residue 117 |
| 06/21/2009 | CA2647856A1 Diagnostic test for cardiomyopathy |
| 06/21/2009 | CA2647712A1 Poplar transcription factors |
| 06/21/2009 | CA2612655A1 Poplar transcription factor myb134 |
| 06/18/2009 | WO2009076638A2 Compositions and methods relating to characterization and therapeutic application of pristine stem cells |
| 06/18/2009 | WO2009076621A1 High resolution structures of acidic mammalian chitinases and uses thereof |
| 06/18/2009 | WO2009076524A2 Polypurine tract modified retroviral vectors |
| 06/18/2009 | WO2009076464A2 Methods for sequential replacement of targeted region by homologous recombination |
| 06/18/2009 | WO2009076400A2 Compositions and methods for inhibiting expression of factor vii gene |
| 06/18/2009 | WO2009076321A2 Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| 06/18/2009 | WO2009076196A1 High copy number self-replicating plasmids in pseudomonas |
| 06/18/2009 | WO2009076122A1 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
| 06/18/2009 | WO2009075954A1 Methods and pharmaceutical compositions for regulation of g- and/or gc-rich nucleic acid expression |
| 06/18/2009 | WO2009075886A1 Compositions and methods related to mrna translational enhancer elements |
| 06/18/2009 | WO2009075882A2 Impaired wound healing compositions and treatments |
| 06/18/2009 | WO2009075860A2 Transgenic plants with enhanced agronomic traits |
| 06/18/2009 | WO2009075815A1 Immunomodulating gene therapy |
| 06/18/2009 | WO2009075811A1 Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| 06/18/2009 | WO2009075798A2 Hydrogenase polypeptide and methods of use |
| 06/18/2009 | WO2009075376A1 Anti-ofloxacin monoclonal antibody and immunoassay method of ofloxacin using the same |
| 06/18/2009 | WO2009075236A1 Needle |
| 06/18/2009 | WO2009075234A1 Chip drive |
| 06/18/2009 | WO2009075119A1 Effective nucleus initialization method |
| 06/18/2009 | WO2009075111A1 Bacteriolysis-resistant cell and method for production thereof |
| 06/18/2009 | WO2009074970A2 Means for delivery of nucleic acids active for gene silencing using synthetic polymers |
| 06/18/2009 | WO2009074873A1 Improved chimeric meganuclease enzymes and uses thereof |
| 06/18/2009 | WO2009074843A1 Genetically modified plants displaying reduced accumulation of cadmium |
| 06/18/2009 | WO2009074842A1 Improved chimeric meganuclease enzymes and uses thereof |
| 06/18/2009 | WO2009074707A1 Grk2 antitumour therapy |
| 06/18/2009 | WO2009074337A1 METHOD OF GENERATING ρ0 CELLS |
| 06/18/2009 | WO2009074325A1 Transgenic plants modified for reduced cadmium transport, derivative products, and related methods |
| 06/18/2009 | WO2009074076A1 A complex molecule interfering the expression of target genes and its preparing methods |
| 06/18/2009 | WO2009073984A1 High-density lipoprotein-like peptide-phospholipid scaffold ('hpps') nanoparticles |
| 06/18/2009 | WO2009073977A1 Polypeptides modified by protein trans-splicing technology |
| 06/18/2009 | WO2009073975A1 Production of recombinant interferon proteins |
| 06/18/2009 | WO2009073905A2 Method for increasing immunoreactivity |
| 06/18/2009 | WO2009059254A3 Methods for the economical production of biofuel precursor that is also a biofuel from biomass |
| 06/18/2009 | WO2009055773A3 Methods for identifying fragile histidine triad (fhit) interaction and uses thereof |
| 06/18/2009 | WO2009054735A3 Polynucleotides and methods for the improvement of plants |
| 06/18/2009 | WO2009049147A3 Method of tumor screening by detection of tumour marker in low molecular weight nucleic acid from urine |
| 06/18/2009 | WO2009045356A8 Microrna compositions in the treatment of vegf-mediated disorders |
| 06/18/2009 | WO2009043173A8 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 06/18/2009 | WO2009039507A3 Identification and isolation of fetal cells and nucleic acid |
| 06/18/2009 | WO2009035971A3 Compositions and methods for preventing influenza infection in canines, felines and equines |
| 06/18/2009 | WO2009031835A4 Cell permeable nm23 recombinant proteins, polynucleotides encoding the same, and anti-metastatic composition comprising the same |
| 06/18/2009 | WO2009027313A3 Pathogen control genes and methods of use in plants |
| 06/18/2009 | WO2009026580A3 Maize promoter active in silk and pericarp tissues |
| 06/18/2009 | WO2009024239A3 Permissive cells and uses thereof |
| 06/18/2009 | WO2009024208A9 Hypoallergenic molecules |
| 06/18/2009 | WO2009024142A3 Protease-stable, cell wall-lysing enzymes |
| 06/18/2009 | WO2009017670A3 Ras-mediated epigenetic silencing effectors and uses thereof |
| 06/18/2009 | WO2009016202A3 Desaturases and methods for producing polyunsaturated fatty acids in transgenic organisms |
| 06/18/2009 | WO2009014878A3 Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| 06/18/2009 | WO2009012786A3 Nanoparticle-mediated treatment for inflammatory diseases |
| 06/18/2009 | WO2008156655A3 Vaccinia virus vectors encoding a sodium-dependent transporter protein for imaging and/or treatment of tumors |
| 06/18/2009 | WO2008109167A3 Variant activin receptor polypeptides and uses thereof |
| 06/18/2009 | WO2008060489A9 Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals |
| 06/18/2009 | WO2007137329A3 Multi-gene expression vehicle |
| 06/18/2009 | WO2007109749A8 Methods for preventing and treating amyloidogenic diseases |
| 06/18/2009 | WO2007059303A3 Compositions for coordinated vegf and pdgf expression, and methods of use |
| 06/18/2009 | WO2007053207A3 Methods for controlling stem cell differentiation |
| 06/18/2009 | WO2007021841A3 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 06/18/2009 | WO2005084366A3 Transcription factor rna interference reagents and methods of use thereof |
| 06/18/2009 | WO2004055156A3 A vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosis |
| 06/18/2009 | WO2004046335A3 A method for cloning of a rare, specifically mutated cell |
| 06/18/2009 | WO2004024077A3 Novel composition and methods for the treatment of psoriasis |
| 06/18/2009 | WO2004016745A3 Backterial effector proteins which inhibit programmed cell death |
| 06/18/2009 | WO2003089458A3 Conjugates of membrane translocating agents and pharmaceutically active agents |
| 06/18/2009 | WO2003072760A3 Method for cloning and expression of bsawi restriction endonuclease and bsawi methylase in e. coli |
| 06/18/2009 | WO2003000909A3 Methods for the manufacture of pure single enantiomer compounds and for selecting enantioselective enzymes |
| 06/18/2009 | WO2002079494A3 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |